Results (3623)
Question-and-answer document clarifies regulatory requirements for devices used in combination with medicines
EMA launches fifth communication perception survey
The European Medicines Regulatory Network (EMRN) has been designated as WHO Listed Authority (WLA) by the World Health Organization (WHO).
Review of studies raises possible safety concern and finds no effect in preventing premature birth
Hydroxyprogesterone caproate medicines to be suspended from the EU market
The European Medicines Agency's (EMA) office is closed from 18:00 on Friday 17 May 2024 to 07:30 on Tuesday 21 May 2024. Outside of working hours and on public holidays, it is possible to call the product emergency hotline on +31(0)88 781 7600.
EMA’s human medicines committee (CHMP) recommended eight medicines for approval at its April 2024 meeting.
The European Medicines Agency's (EMA) office is closed from 18:00 on Wednesday 8 May 2024 to 07:30 on Monday 13 May 2024. Outside of working hours and on public holidays, it is possible to call the product emergency hotline on +31(0)88 781 7600.
Today, the European Centre for Disease Prevention and Control (ECDC), the European Chemicals Agency (ECHA), the European Environment Agency (EEA), the European Food Safety Authority (EFSA), and the European Medicines Agency (EMA) published a joint framework for action to strengthen cooperation to support the implementation of the One Health agenda...